Neurological and endocrinological disorders: Orphans in chronic obstructive pulmonary disease

Respiratory Medicine

Volumn 105, Issue SUPPL. 1, 2011, Pages

  Doehner, Wolfram ^a   Haeusler, Karl Georg ^a   Endres, Matthias ^a   Anker, Stefan D ^a,b   MacNee, William ^c   Lainscak, Mitja ^a,d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY CLINIC OF RESPIRATORY AND ALLERGIC DISEASES   (Slovenia)

Author keywords

Chronic obstructive pulmonary disease; Diabetes mellitus; Insulin resistance; Metabolic syndrome; Stroke

Indexed keywords

ADVERSE OUTCOME; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ENDOCRINE DISEASE; HUMAN; INSULIN RESISTANCE; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; STROKE; WHITE MATTER;

COMORBIDITY; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; STROKE;

EID: 80055022189     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/S0954-6111(11)70005-1     Document Type: Article

References (77)

1. PJ Barnes, BR Celli Systemic manifestations and comorbidities of COPD Eur Respir J 33 2009 1165 1185
2. W Doehner, S von Haehling, SD Anker, M Lainscak Neurohormonal activation and inflammation in chronic cardiopulmonary disease: a brief systematic review Wien Klin Wochenschr 121 2009 293 296
3. DD Sin, NR Anthonisen, JB Soriano, AG Agusti Mortality in COPD: role of comorbidities Eur Respir J 28 2006 1245 1257 (Pubitemid 44883863)
4. J Finkelstein, E Cha, SM Scharf Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity Int J Chron Obstruct Pulmon Dis 4 2009 337 349
5. E Loh, MS Sutton, CC Wun, JL Rouleau, GC Flaker, SS Gottlieb et al. Ventricular dysfunction and the risk of stroke after myocardial infarction N Engl J Med 336 1997 251 257 (Pubitemid 27044626)
6. PM Pullicino, JL Halperin, JL Thompson Stroke in patients with heart failure and reduced left ventricular ejection fraction Neurology 54 2000 288 294 (Pubitemid 30078055)
7. PA Wolf, RD Abbott, WB Kannel Atrial fibrillation is an independent risk factor for stroke: The Framingham study Stroke 22 1991 983 988
8. JR Feary, LC Rodrigues, CJ Smith, RB Hubbard, JE Gibson Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care Thorax 65 2010 956 962
9. SM Curkendall, C DeLuise, JK Jones et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients Arm Epidemiol 16 2006 63 70 (Pubitemid 41783891)
10. JG Schanen, C Iribarren, E Shahar, NM Punjabi, SS Rich, PD Sorlie et al. Asthma and incident cardiovascular disease: the Atherosclerosis Risk in Communities Study Thorax 60 2005 633 638 (Pubitemid 41129060)
11. AJ Grau, MR Preusch, F Palm, C Lichy, H Becher, F Buggle Association of symptoms of chronic bronchitis and frequent flulike illnesses with stroke Stroke 40 2009 3206 3210
12. G Pinol-Ripoll, I de la Puerta, S Santos, F Purroy, E Mostacero Chronic bronchitis and acute infections as new risk factors for ischemic stroke and the lack of protection offered by the influenza vaccination Cerebrovasc Dis 26 2008 339 347
13. DD Sin, SF Man Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality Proc Am Thorac Soc 2 2005 8 11 (Pubitemid 40562956)
14. HC Emsley, SJ Hopkins Acute ischaemic stroke and infection: recent and emerging concepts Lancet Neurol 7 2008 341 353 (Pubitemid 351380535)
15. R Ross Atherosclerosis: an inflammatory disease N Engl J Med 340 1999 115 126
16. YB Park, CW Ahn, HK Choi, SH Lee, BH In, HC Lee et al. Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound Arthritis Rheum 46 2002 1714 1719 (Pubitemid 34774501)
17. FL Fimognari, S Scarlata, ME Conte, RA Incalzi Mechanisms of atherothrombosis in chronic obstructive pulmonary disease Int J Chron Obstruct Pulmon Dis 3 2008 89 96 (Pubitemid 351523720)
18. PJ Lindsberg, AJ Grau Inflammation and infections as risk factors for ischemic stroke Stroke 34 2003 2518 2532 (Pubitemid 37221976)
19. R Sabit, P Thomas, DJ Shale, P Collins, SJ Linnane The effects of hypoxia on markers of coagulation and systemic inflammation in patients with chronic obstructive pulmonary disease Chest 2010 138 2010 47 51
20. Y Jiang, W Xiao, Y Zhang, Y Xing Urokinase-type plasminogen activator system and human cationic antimicrobial protein 18 in serum and induced sputum of patients with chronic obstructive pulmonary disease Respirology 15 2010 939 946
21. P Eickhoff, A Valipour, D Kiss, M Schreder, L Cekici, K Geyer et al. Determinants of Systemic Vascular Function in Patients with Stable Chronic Obstructive Pulmonary Disease Am J Respir Crit Care Med 178 2008 1211 1218
22. JD Maclay, DA McAllister, NL Mills, FP Paterson, CA Ludlam, EM Drost, DE Newby, W Macnee Vascular dysfunction in chronic obstructive pulmonary disease Am J Respir Crit Care Med 180 2009 513 520
23. G Cella, A Sbarai, G Mazzaro, B Vanzo, S Romano, T Hoppensteadt et al. Plasma markers of endothelial dysfunction in chronic obstructive pulmonary disease Clin Appl Thromb Hemost 7 2001 205 208 (Pubitemid 32574181)
24. G Davi, S Basili, M Vieri, F Cipollone, S Santarone, C Alessandri et al. Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease. The Chronic Obstructive Bronchitis and Haemostasis Study Group Am J Respir Crit Care Med 156 1997 1794 1799 (Pubitemid 28011784)
25. O Miyamoto, RN Auer Hypoxia, hyperoxia, ischemia, and brain necrosis Neurology 54 2000 362 371 (Pubitemid 30078067)
26. EJ van Dijk, SE Vermeer, JC deGroot, J van de Minkelis, ND Prins et al. Arterial oxygen saturation, COPD, and cerebral small vessel disease J Neurol Neurosurg Psychiatry 75 2004 733 736 (Pubitemid 38526685)
27. S Andreas, SD Anker, PD Scanlon, V Somers Neurohormonal activation as a link to systemic manifestations of chrojnic lung disease Chest 128 2005 3618 3624 (Pubitemid 41698701)
28. WT McNicholas Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease Am J Respir Crit Care Med 180 2009 692 700
29. M Arzt, T Young, L Finn et al. Association of sleep-disordered breathing and the occurrence of stroke Am J Respir Crit Care Med 172 2005 1447 1451 (Pubitemid 43069819)
30. N Scherbakov, W Doehner Sarcopenia in stroke - facts and numbers on muscle loss accounting for disability after stroke J Cachexia Sarcopenia Muscle 2 2011 5 8
31. F Koehler, W Doehner, S Hoernig, C Witt, SD Anker, M John Anorexia in chronic obstructive pulmonary disease-association to cachexia and hormonal derangement Int J Cardiol 119 2007 83 89 (Pubitemid 46818476)
32. FM Franssen, HP Sauerwein, EP Rutten, EF Wouters, AM Schols Whole-body resting and exercise-induced lipolysis in sarcopenic (corrected) patients with COPD Eur Respir J 32 2008 1466 1471
33. K Fearon, WJ Evans, SD Anker Myopenia-a new universal term J Cachexia Sarcopenia Muscle 2 2011 1 3
34. N Scherbakov, U Dirnagl, W Doehner Body weight after stroke: Lessons from the obesity paradox Stroke 42 2011 doi: 10.1161
35. A Hozawa, JL Billings, E Shahar, T Ohira, WD Rosamond, AR Folsom Lung function and ischemic stroke incidence: the Atherosclerosis Risk in Communities study Chest 130 2006 1642 1649 (Pubitemid 46033414)
36. T Truelsen, E Prescott, P Lange, P Schnohr, G Boysen Lung function and risk of fatal and non-fatal stroke. The Copenhagen City Heart Study Int J Epidemiol 30 2001 145 151 (Pubitemid 32203804)
37. SE Vermeer, M Hollander, EJ van Dijk, A Hofman, PJ Koudstaal, MM Breteler, Rotterdam Scan Study Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study Stroke 34 2003 1126 1129 (Pubitemid 36547501)
38. D Liao, M Higgins, NR Bryan, ML Eigenbrodt, LE Chambless, V Lamar et al. Lower pulmonary function and cerebral subclinical abnormalities detected by MRI: the Atherosclerosis Risk in Communities study Chest 116 1999 150 156 (Pubitemid 29340276)
39. WT Longstreth Jr, TA Manolio, A Arnold, GL Burke, N Bryan, CA Jungreis, PL Enright, D O'Leary, L Fried Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study Stroke 27 1996 1274 1282 (Pubitemid 26286152)
40. S Borson, J Scanlan, S Friedman, E Zuhr, J Fields, E Aylward et al. Modeling the impact of COPD on the brain Int J Chron Obstruct Pulmon Dis 3 2008 429 434
41. S Debette, HS Markus The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis BMJ 2010 341 3666
42. JW Dodd, SV Getov, PW Jones Cognitive function in COPD Eur Respir J 35 2010 913 922
43. SJ Pressler Cognitive functioning and chronic heart failure: a review of the literature J Cardiovasc Nurs 23 2008 239 249
44. LP McGarvey, M John, JA Anderson, M Zvarich, RA Wise Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee Thorax 62 2007 411 415 (Pubitemid 46698390)
45. B Roca, P Almagro, F Lopez, FJ Cabrera, L Montero, D Morchon for the ECCO Working Group on COPD, Spanish Society of Internal Medicine Factors associated with mortality in patients with exacerbation of chronic obstructive pulmonary disease hospitalized in General Medicine departments Intern Emery Med 6 2011 47 54
46. DJ Hole, GC Watt, G Davey-Smith, CL Hart, CR Gillis, VM Hawthorne Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study BMJ 313 1996 711 716 (Pubitemid 26313070)
47. OM Ronning, B Guldvog Should stroke victims routinely receive supplemental oxygen? A quasi-randomized controlled trial Stroke 30 1999 2033 2037 (Pubitemid 29473245)
48. HK Shin, AK Dunn, PB Jones, DA Boas, EH Lo, MA Moskowitz et al. Normobaric hyperoxia improves cerebral blood flow and oxygenation, and inhibits peri-infarct depolarizations in experimental focal ischaemia Brain 130 2007 1631 1642 (Pubitemid 47355921)
49. European Stroke Organisation (ESO) Executive Committee, ESO Writing Committee Guidelines for management of ischaemic stroke and transient ischaemic attack 2008 Cerebrovasc Dis 25 2008 457 507
50. M Lainscak, N Dagres, GS Filippatos, SD Anker, DT Kremastinos Atrial fibrillation in chronic non-cardiac disease: where do we stand? Int J Cardiol 128 2008 311 315
51. EC Creutzberg, R Casaburi Endocrinological disturbances in chronic obstructive pulmonary disease Eur Respir J 22 Suppl 46 2003 76s 80s (Pubitemid 37351739)
52. F Laghi, N Adiguzel, MJ Tobin Endocrinological derangements in COPD Eur Respir J 34 2009 975 996
53. LM Fabbri, F Luppi, B Beghe, KF Rabe Complex chronic comorbidities of COPD Eur Respir J 31 2008 204 212
54. D Mozaffarian, A Kamineni, M Carnethon, L Djousse, KJ Mukamal, D Siscovick Lifestyle risk factors and new-onset diabetes mellitus in older adults: the cardiovascular health study Arch Intern Med 169 2009 798 807
55. AL Rosenbloom, JH Silverstein, S Amemiya, P Zeitler, GJ Klingensmith Type 2 diabetes in children and adolescents Pediatr Diabetes 10 Suppl 12 2009 17 32
56. JB Meigs Epidemiology of type 2 diabetes and cardiovascular disease: translation from population to prevention: the Kelly West award lecture 2009 Diabetes Care 33 2010 1865 1871
57. KG Alberti, P Zimmet, J Shaw Metabolic syndrome-a new worldwide definition. A Consensus Statement from the International Diabetes Federation Diabet Med 23 2006 469 480
58. SM Grundy, HB Brewer, Jl Cleeman, SC Smith, D Lenfant, for the Conference Participants Definition of metabolic syndrome: report of the National, Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition Circulation 109 2004 433 438 (Pubitemid 38133916)
59. G Federspil, E Nisoli, R Vettor A critical reflection on the definition of metabolic syndrome Pharmacol Res 53 2006 449 456 (Pubitemid 43767550)
60. M Lainscak, W Doehner, SD Anker Metabolic disturbances in chronic heart failure: a case for the "macho" approach with testosterone? Eur J Heart Fail 9 2007 2 3 (Pubitemid 46074484)
61. W Doehner, SD Anker, IF Godsland Optimizing insulin sensitivity assessment using the minimal model in chronic heart failure Horm Metab Res 37 2005 106 110 (Pubitemid 40445132)
62. CE Bolton, M Evans, AA lonescu, SM Edwards, RHK Morris, G Dunseath et al. Insulin resistance and inflammation - a further systemic complication of COPD COPD 4 2007 121 126 (Pubitemid 47164861)
63. S Eker, L Ayaz, L Tamer, B Ulubas Leptin, visfatin, insulin resistance, and body composition change in chronic obstructive pulmonary disease Scand J Clin Lab Invest 70 2010 40 44
64. HP Sauerwein, AMWJ Schols Glucose metabolism in chronic lung disease Clin Nutr 21 2002 367 371
65. H Watz, B Waschki, A Kirsten, KC Muller, G Kretschmar et al. The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity Chest 136 2009 1039 1046
66. KB Lam, RE Jordan, CQ Jiang, GN Thomas, MR Miller, WS Zhang et al. Airflow obstruction and metabolic syndrome: the Guangzhou Biobank Cohort Study Eur Respir J 35 2010 317 323
67. JA Walters, EH Walters, R Wood-Baker Oral corticosteroids for stable chronic obstructive pulmonary disease Cochrane Database Syst Rev 3 2005 CD005374.
68. RE Walter, A Beiser, RJ Givelber, GT O'Connor, DJ Gottlieb Association between glycemic state and lung function: the Framingham Heart Study AM J Respir Crit Care Med 167 2003 911 916 (Pubitemid 36801781)
69. ES Ford, DM Mannino Prospective association between lung function and the incidence of diabetes: findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study Diabetes Care 27 2004 2966 2970 (Pubitemid 39565067)
70. DM Mannino, D Thorn, A Swensen, F Holguin Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD Eur RespirJ 32 2008 962 969
71. A Parappil, B Depczynski, P Collett, GB Marks Effect of comorbid diabetes on length of stay and risk of death in patients addmitted with acute exacerbations of COPD Respirology 15 2010 918 922
72. K Rave, A de la Peha, FS Tibaldi, L Zhang, B Silverman, M Hausmann et al. AIR inhaled insulin in subjects with chronic obstructive pulmonary disease: pharmacokinetics, glucodynamics, safety, and tolerability Diabetes Care 30 2007 1777 1782 (Pubitemid 47036351)
73. HJ Kim, JY Lee, HS Jung, DK Kim, SM Lee, JJ Yim et al. The impact of insulin sensitisers on lung function in patients with chronic obstructive pulmonary disease and diabetes Int J Tuberc Lung Dis 14 2010 362 367
74. M Lainscak, S von Haehling, W Doehner, I Sarc, T Jeric, K Ziherl et al. Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease J Cachexia Sarcopenia Muscle 2 2011 81 86
75. M Rauchhaus, AL Clark, W Doehner, C Davos, A Bolger, R Sharma et al. The relationship between cholesterol and survival in patients with chronic heart failure J Am Coll Cardiol 42 2003 1933 1940 (Pubitemid 37485568)
76. A Agusti, PM Calverley, B Celli, HO Coxson, LD Edwards, DA Lomas et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort Respir Res 11 2010 122
77. I Sarc, T Jeric, K Ziherl, S Suskovic, M Kosnik, SD Anker et al. Adherence to treatment guidelines and long-term survival in hospitalized patients with chronic obstructive pulmonary disease J Eval Clin Pract 17 2011 737 743